Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RYTHM Inc | Raymond Chang | Director, Chairman and CEO, Ten Percent Owner | 21 May 2024 | 7,876,712 | 7,876,712 | - | - | Pre-Funded Warrants (right to buy) | ||
| RYTHM Inc | I-Tseng Jenny Chan | Director, Ten Percent Owner | 21 May 2024 | 7,876,712 | 7,876,712 | - | - | Pre-Funded Warrants (right to buy) | ||
| RYTHM Inc | Raymond Chang | Director, Chairman and CEO, Ten Percent Owner | 21 May 2024 | 7,383,053 | 7,383,053 | - | - | Pre-Funded Warrants (right to buy) | ||
| Biodesix Inc | Lawrence T. Kennedy | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 2,608,720 | 2,775,386 | - | - | Common Stock | |
| Doximity Inc (Class A) | Kevin Spain | Director | 21 May 2024 | 1,928,000 | 10,606,728 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Kevin Spain | Director | Other type of transaction at price $ 0.00 per share. | 21 May 2024 | 1,928,000 | 0 | - | 0 | Class A Common Stock | |
| Doximity Inc (Class A) | Kevin Spain | Director | 21 May 2024 | 1,928,000 | 1,928,000 | - | 0 | Class A Common Stock | ||
| Biodesix Inc | Lawrence T. Kennedy | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 1,739,120 | 12,267,873 | - | - | Common Stock | |
| Bed Bath & Beyond Inc | Marcus A. Lemonis | Director, EXECUTIVE CHAIRMAN OF BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 1,000,000 | 1,000,000 | - | - | Stock Option (right to buy) | |
| Bed Bath & Beyond Inc | Marcus A. Lemonis | Director, EXECUTIVE CHAIRMAN OF BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 750,000 | 750,000 | - | - | Stock Option (right to buy) | |
| Procore Tech Inc | William J.G. Griffith | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 21 May 2024 | 696,548 | 3,760,501 | - | - | Common Stock | |
| ADT Inc | Donald M. Young | EVP & COO | 21 May 2024 | 614,638 | 2,332,704 (0%) | 0% | 0 | Common Stock | ||
| ADT Inc | Jeff Likosar | Pres Corp Dev & Trans. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 573,387 | 1,162,909 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 559,597 | 3,006,339 (0%) | 0% | 0 | Common Stock | |
| Procore Tech Inc | William J.G. Griffith | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 21 May 2024 | 545,256 | 2,943,716 | - | - | Common Stock | |
| Bed Bath & Beyond Inc | Marcus A. Lemonis | Director, EXECUTIVE CHAIRMAN OF BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Oncology Institute Inc | Daniel Virnich | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 496,293 | 496,293 | - | - | Non-Qualified Stock Option (right to buy) | |
| Inspired Entertainment Inc | A. Lorne Weil | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 21 May 2024 | 493,015 | 493,015 (2%) | 2% | 0 | Common Stock | |
| Inspired Entertainment Inc | A. Lorne Weil | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 21 May 2024 | 493,015 | 0 (0%) | 2% | 0 | Common Stock | |
| ADT Inc | Jeff Likosar | Pres Corp Dev & Trans. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 397,411 | 1,192,233 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 387,853 | 1,163,560 | - | - | Employee Stock Option (right to buy) | |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 378,648 | 378,648 | - | - | Non-Qualified Stock Option (right to buy) | |
| ADT Inc | Donald M. Young | EVP & COO | 21 May 2024 | 356,160 | 1,068,480 | - | - | Employee Stock Option (right to buy) | ||
| LM Funding America Inc | Bruce M. Rodgers | Director, Chairman, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 May 2024 | 343,399 | 343,399 | - | - | Warrant | |
| LM Funding America Inc | Richard D. Russell | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 May 2024 | 329,933 | 329,933 | - | - | Warrant | |
| Privia Health Group Inc | Adam Boehler | Director | 21 May 2024 | 277,565 | 5,488,701 | - | 16.2 | 4,488,226 | Common Stock, $0.01 par value per share | |
| Procore Tech Inc | William J.G. Griffith | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 21 May 2024 | 258,196 | 1,413,060 | - | - | Common Stock | |
| Domo Inc (Class B) | Joshua G. James | Director, Founder and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 250,000 | 1,131,765 (4%) | 1% | 0 | Class B Common Stock | |
| DXC Tech Co | Raul F. Fernandez | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 220,610 | 513,245 (0%) | 0% | 0 | Common Stock | |
| Biodesix Inc | John Patience | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 217,400 | 4,829,611 | - | - | Common Stock | |
| Nextracker Inc (Class A) | Daniel S. Shugar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 214,368 | 221,682 | - | 0 | Common Stock | |
| Sphere 3D Corp | Patricia Trompeter | Director, CEO | 21 May 2024 | 210,000 | 1,245,715 | - | - | Restricted Stock Unit (RSU) | ||
| DraftKings Inc (Class A) | Jason D. Robins | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 43.59 per share. | 21 May 2024 | 199,500 | 2,669,454 | - | 43.6 | 8,696,205 | Class A Common Stock |
| Oncology Institute Inc | Daniel Virnich | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 198,517 | 916,947 | - | 0 | Common Stock | |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 21 May 2024 | 187,500 | 874,973 | - | 0.0 | 5,625 | Common Stock |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 187,500 | 2,066,079 | - | - | Stock Option (Right to Buy) | |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.68 per share. | 21 May 2024 | 187,500 | 687,473 | - | 1.7 | 315,075 | Common Stock |
| Oncology Institute Inc | Jeremy N Castle | Chief Operating Officer | 21 May 2024 | 175,299 | 175,299 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Privia Health Group Inc | Adam Boehler | Director | 21 May 2024 | 172,642 | 5,763,572 | - | 16.3 | 2,810,612 | Common Stock, $0.01 par value per share | |
| Immuneering Corp (Class A) | Harold Eugene Brakewood | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 165,000 | 165,000 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Harold Eugene Brakewood | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 165,000 | 0 | - | - | Stock Option | |
| Traeger Inc | Jeremy Andrus | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.17 per share. | 21 May 2024 | 165,000 | 7,428,887 | - | 2.2 | 357,522 | Common Stock |
| DXC Tech Co | Howard Boville | Global Lead Apps Services & AI | 21 May 2024 | 157,403 | 302,003 (0%) | 0% | 0 | Common Stock | ||
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 151,459 | 474,931 | - | 0 | Common Stock | |
| Immuneering Corp (Class A) | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 143,000 | 143,000 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 143,000 | 0 | - | - | Stock Option | |
| Nextracker Inc (Class A) | Daniel S. Shugar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 134,260 | 355,942 | - | 0 | Common Stock | |
| Sphere 3D Corp | Duncan J. McEwan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 125,315 | 286,314 | - | - | Non-Qualified Stock Option (right to buy) | |
| The Baldwin Insurance Grp Inc (Class A) | Lowry Baldwin | Director, Ten Percent Owner, See Remarks | 21 May 2024 | 125,000 | 0 | - | - | LLC Units in The Baldwin Insurance Group Holdings, LLC | ||
| The Baldwin Insurance Grp Inc (Class A) | Lowry Baldwin | Director, Ten Percent Owner, See Remarks | Other type of transaction at price $ 0.00 per share. | 21 May 2024 | 125,000 | 125,000 | - | - | LLC Units in The Baldwin Insurance Group Holdings, LLC | |
| The Baldwin Insurance Grp Inc (Class A) | Lowry Baldwin | Director, Ten Percent Owner, See Remarks | Other type of transaction at price $ 0.00 per share. | 21 May 2024 | 125,000 | 13,149,090 | - | - | LLC Units in The Baldwin Insurance Group Holdings, LLC | |
| The Baldwin Insurance Grp Inc (Class A) | Lowry Baldwin | Director, Ten Percent Owner, See Remarks | 21 May 2024 | 125,000 | 125,000 (0%) | 0% | 0 | Class A Common Stock | ||
| The Baldwin Insurance Grp Inc (Class A) | Lowry Baldwin | Director, Ten Percent Owner, See Remarks | 21 May 2024 | 125,000 | 0 | - | 0 | Class B Common Stock | ||
| The Baldwin Insurance Grp Inc (Class A) | Lowry Baldwin | Director, Ten Percent Owner, See Remarks | Other type of transaction at price $ 0.00 per share. | 21 May 2024 | 125,000 | 125,000 | - | 0 | Class B Common Stock | |
| The Baldwin Insurance Grp Inc (Class A) | Lowry Baldwin | Director, Ten Percent Owner, See Remarks | Other type of transaction at price $ 0.00 per share. | 21 May 2024 | 125,000 | 13,149,090 | - | 0 | Class B Common Stock | |
| DXC Tech Co | Andrew Wilson | Global Lead, Modern Workplace | 21 May 2024 | 121,987 | 181,346 (0%) | 0% | 0 | Common Stock | ||
| DXC Tech Co | Christopher R. Drumgoole | Global Lead, Cloud Inf. & ITO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 120,413 | 376,427 (0%) | 0% | 0 | Common Stock | |
| BuzzFeed Inc (Class A) | Matthew Omer | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 117,188 | 140,950 | - | 0 | Class A Common Stock | |
| BuzzFeed Inc (Class A) | Matthew Omer | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 117,188 | 351,562 | - | - | Restricted Stock Units | |
| Nextracker Inc (Class A) | Howard J. Wenger | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 114,330 | 137,868 | - | 0 | Common Stock | |
| DXC Tech Co | Robert F. Del Bene | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 110,551 | 202,135 (0%) | 0% | 0 | Common Stock | |
| Hims & Hers Health Inc (Class A) | Christopher D. Payne | Director | Purchase of securities on an exchange or from another person at price $ 17.74 per share. | 21 May 2024 | 110,000 | 110,000 | - | 17.7 | 1,951,763 | Class A Common Stock |
| Immuneering Corp (Class A) | Leah R. Neufeld | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 105,000 | 105,000 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Leah R. Neufeld | CHIEF PEOPLE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 105,000 | 0 | - | - | Stock Option | |
| Sphere 3D Corp | Kurt L. Kalbfleisch | CFO | 21 May 2024 | 105,000 | 253,214 | - | - | Restricted Stock Unit (RSU) | ||
| Privia Health Group Inc | Adam Boehler | Director | 21 May 2024 | 102,229 | 5,590,930 | - | 16.4 | 1,679,622 | Common Stock, $0.01 par value per share | |
| Nextracker Inc (Class A) | Daniel S. Shugar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 102,019 | 102,019 | - | - | Stock Option (Right to Buy) | |
| Tigo Energy Inc | Michael R. Splinter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 101,626 | 164,600 | - | 0 | Common Stock | |
| Tigo Energy Inc | Stanley B. Stern | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 101,626 | 287,048 | - | 0 | Common Stock | |
| Tigo Energy Inc | Joan C. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 101,626 | 117,930 | - | 0 | Common Stock | |
| Tigo Energy Inc | Sagit Manor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 101,626 | 226,626 | - | 0 | Common Stock | |
| Tigo Energy Inc | Tomer Babai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 101,626 | 117,930 | - | 0 | Common Stock | |
| Immuneering Corp (Class A) | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 101,116 | 0 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 101,116 | 101,116 | - | - | Stock Option | |
| BuzzFeed Inc (Class A) | David Arroyo | CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 100,572 | 111,913 | - | 0 | Class A Common Stock | |
| BuzzFeed Inc (Class A) | David Arroyo | CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 100,572 | 201,152 | - | - | Restricted Stock Units | |
| Curis Inc | James E. Dentzer | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 100,000 | 100,000 | - | - | Employee stock option (right to buy) | |
| Invivyd Inc | Kevin F. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Srishti Gupta | Director | 21 May 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Atlas Energy Soln Inc (Class A) | Chad M. McEver | Ten Percent Owner, Member of 10% Owner Group | Sale of securities on an exchange or to another person at price $ 24.55 per share. | 21 May 2024 | 100,000 | 451,755 | - | 24.6 | 2,455,000 | Common Stock |
| Sphere 3D Corp | Timothy P. Hanley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 96,154 | 153,625 | - | - | Restricted Stock Unit (RSU) | |
| Nextracker Inc (Class A) | David Bennett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 95,274 | 111,726 | - | 0 | Common Stock | |
| Talkspace Inc | Katelyn Watson | Director, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 21 May 2024 | 94,018 | 478,473 | - | 2.7 | 253,849 | Common Stock |
| Immuneering Corp (Class A) | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 93,000 | 93,000 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 93,000 | 0 | - | - | Stock Option | |
| The Baldwin Insurance Grp Inc (Class A) | Lowry Baldwin | Director, Ten Percent Owner, See Remarks | Sale of securities on an exchange or to another person at price $ 34.24 per share. | 21 May 2024 | 92,890 | 0 (0%) | 0% | 34.2 | 3,180,554 | Class A Common Stock |
| QVC Group Inc Ordinary | David L. Rawlinson | Director, President/CEO | Purchase of securities on an exchange or from another person at price $ 0.72 per share. | 21 May 2024 | 90,600 | 1,443,666 (0%) | 0% | 0.7 | 65,223 | Series A Common Stock |
| Pioneer Bancorp Inc | Thomas L Amell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 90,000 | 90,000 (0%) | 0% | 0 | Common Stock | |
| Immuneering Corp (Class A) | Leah R. Neufeld | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 88,600 | 88,600 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Leah R. Neufeld | CHIEF PEOPLE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 88,600 | 0 | - | - | Stock Option | |
| Biodesix Inc | Jack W. Schuler | Director, Ten Percent Owner | 21 May 2024 | 86,960 | 30,794,682 | - | - | Common Stock | ||
| Nextracker Inc (Class A) | Howard J. Wenger | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 85,016 | 85,016 | - | - | Stock Option (Right to Buy) | |
| Walmart | John David Rainey | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.18 per share. | 21 May 2024 | 80,292 | 441,321 (0%) | 0% | 64.2 | 5,153,153 | Common |
| Erasca Inc | Alexander W. Casdin | Director | Purchase of securities on an exchange or from another person at price $ 2.27 per share. | 21 May 2024 | 80,000 | 573,974 | - | 2.3 | 181,920 | Common Stock |
| Nextracker Inc (Class A) | Daniel S. Shugar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 79,786 | 143,536 | - | - | Performance Stock Units | |
| McKesson | Brian S. Tyler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 72,026 | 115,471 (0%) | 0% | 0 | Common Stock | |
| Immuneering Corp (Class A) | Mallory Morales | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 72,000 | 72,000 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Mallory Morales | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 72,000 | 0 | - | - | Stock Option | |
| Booz Allen Hamilton Holding Corp (Class A) | Horacio D. Rozanski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 71,575 | 613,596 (0%) | 0% | 0 | Class A Common Stock | |
| Oncology Institute Inc | Jeremy N Castle | Chief Operating Officer | 21 May 2024 | 70,120 | 82,460 | - | 0 | Common Stock | ||
| Domo Inc (Class B) | Daren Thayne | CTO & EVP of Product | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 70,000 | 413,758 (1%) | 0% | 0 | Class B Common Stock | |
| Domo Inc (Class B) | David Jolley | Chief Financial Officer | 21 May 2024 | 70,000 | 285,543 (1%) | 0% | 0 | Class B Common Stock | ||
| DXC Tech Co | Mary E. Finch | EVP, CHRO & Global Lead, Mktg | 21 May 2024 | 68,864 | 408,676 (0%) | 0% | 0 | Common Stock | ||
| DXC Tech Co | James Michael Brady | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 68,864 | 324,542 (0%) | 0% | 0 | Common Stock | |
| Honest Co Inc (The ) | Katherine Barton | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 21 May 2024 | 67,930 | 933,005 | - | 2.8 | 188,166 | Common Stock |
| Nextracker Inc (Class A) | Howard J. Wenger | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 67,130 | 204,998 | - | 0 | Common Stock | |
| Tigo Energy Inc | Michael R. Splinter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 66,506 | 218,669 | - | 0 | Common Stock | |
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 35.92 per share. | 21 May 2024 | 66,330 | 668,182 (0%) | 0% | 35.9 | 2,382,507 | Class A Common Stock |
| biote Corp (Class A) | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 65,258 | 175,459 | - | - | Stock Option (Right to Buy) | |
| biote Corp (Class A) | Steven J. Heyer | Director | 21 May 2024 | 65,258 | 175,459 | - | - | Stock Option (Right to Buy) | ||
| biote Corp (Class A) | Debra L. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 65,258 | 153,657 | - | - | Stock Option (Right to Buy) | |
| biote Corp (Class A) | Dana Jacoby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 65,258 | 143,763 | - | - | Stock Option (Right to Buy) | |
| biote Corp (Class A) | Stephen Mark Cone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 65,258 | 143,763 | - | - | Stock Option (Right to Buy) | |
| Biodesix Inc | Lawrence T. Kennedy | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 65,218 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| DXC Tech Co | Matthew K. Fawcett | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 63,945 | 63,945 (0%) | 0% | 0 | Common Stock | |
| Traeger Inc | Jeremy Andrus | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 21 May 2024 | 63,323 | 7,263,887 | - | 2.2 | 139,925 | Common Stock |
| Soleno Therapeutics Inc | Ernest Mario | Director | 21 May 2024 | 62,000 | 186,566 (0%) | 0% | 4.5 | 279,000 | Common Stock | |
| Soleno Therapeutics Inc | Ernest Mario | Director | 21 May 2024 | 62,000 | 0 | - | - | Warrant (right to buy) | ||
| Confluent Inc (Class A) | Eric Vishria | Director | Sale of securities on an exchange or to another person at price $ 31.41 per share. | 21 May 2024 | 61,905 | 1,371,068 | - | 31.4 | 1,944,436 | Class A Common Stock |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 60,766 | 60,766 | - | - | Restricted Stock Units | |
| Immuneering Corp (Class A) | Mallory Morales | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 60,500 | 60,500 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Mallory Morales | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 60,500 | 0 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Leah R. Neufeld | CHIEF PEOPLE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 60,500 | 0 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Leah R. Neufeld | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 60,500 | 60,500 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Harold Eugene Brakewood | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 60,500 | 60,500 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Harold Eugene Brakewood | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 60,500 | 0 | - | - | Stock Option | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 57,246 | 57,246 | - | - | Restricted Stock Units | |
| Nextracker Inc (Class A) | Nicholas Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 57,165 | 68,279 | - | 0 | Common Stock | |
| Harvard Bioscience Inc | Bertrand Loy | Director | 21 May 2024 | 56,575 | 56,575 (0%) | 0% | 0 | Common Stock | ||
| Tigo Energy Inc | Michael R. Splinter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 54,069 | 265,339 | - | 0 | Common Stock | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 40.64 per share. | 21 May 2024 | 53,006 | 1,592,386 | - | 40.6 | 2,154,302 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 40.64 per share. | 21 May 2024 | 52,818 | 2,044,317 | - | 40.6 | 2,146,772 | Class A Common Stock |
| Kinder Morgan (Class P) | Dax A. Sanders | VP (Pres., Products Pipelines) | Sale of securities on an exchange or to another person at price $ 19.75 per share. | 21 May 2024 | 50,000 | 259,069 (0%) | 0% | 19.8 | 987,515 | Class P Common Stock |
| Pioneer Bancorp Inc | Patrick J. Hughes | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 50,000 | 60,087 (0%) | 0% | 0 | Common Stock | |
| Pioneer Bancorp Inc | Jesse Tomczak | EVP and CCEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Bed Bath & Beyond Inc | David J. Nielsen | DIVISION CEO OVERSTOCK | 21 May 2024 | 50,000 | 150,000 | - | - | Performance Shares | ||
| Invivyd Inc | Terrance G. Mcguire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Marc Elia | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Tamsin Berry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Christine Lindenboom | Director | 21 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | ||
| TMC the metals Co Inc | Anthony O’Sullivan | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 21 May 2024 | 50,000 | 896,829 | - | 1.4 | 69,740 | Common Shares |
| International Bancshares Corp | Antonio R. Sanchez | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 58.39 per share. | 21 May 2024 | 49,888 | 1,232,245 (1%) | 0% | 58.4 | 2,912,960 | Common Stock |
| Nextracker Inc (Class A) | Howard J. Wenger | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 49,286 | 88,666 | - | - | Performance Stock Units | |
| Passage Bio Inc | Maxine Gowen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | |
| Passage Bio Inc | Saqib Islam | Director | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | ||
| Passage Bio Inc | Athena Countouriotis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | |
| Passage Bio Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | |
| Nextracker Inc (Class A) | Leah Schlesinger | GC, Ch Eth & Compl Offr & Sec | 21 May 2024 | 47,637 | 59,547 | - | 0 | Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 21 May 2024 | 47,570 | 47,570 | - | - | Class A Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 21 May 2024 | 47,570 | 50,147,150 | - | - | Class B Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.12 per share. | 21 May 2024 | 47,570 | 0 | - | 21.1 | 1,004,674 | Class A Common Stock |
| Immuneering Corp (Class A) | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,300 | 47,300 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 47,300 | 0 | - | - | Stock Option | |
| Biodesix Inc | Jack W. Schuler | Director, Ten Percent Owner | 21 May 2024 | 46,686 | 46,686 | - | - | Restricted Stock Units | ||
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 46,686 | 46,686 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 46,686 | 46,686 | - | - | Restricted Stock Units | |
| Biodesix Inc | Charles Watts | Director | 21 May 2024 | 46,686 | 46,686 | - | - | Restricted Stock Units | ||
| Biodesix Inc | Lawrence T. Kennedy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 46,686 | 46,686 | - | - | Restricted Stock Units | |
| Roblox Corp (Class A) | Manuel Bronstein | Chief Product Officer | 21 May 2024 | 46,494 | 814,112 | - | 32.6 | 1,513,798 | Class A Common Stock | |
| Harvard Bioscience Inc | Alan I. Edrick | Director | 21 May 2024 | 45,872 | 273,911 (0%) | 0% | 0 | Common Stock | ||
| Harvard Bioscience Inc | Thomas W. Loewald | Director | 21 May 2024 | 45,872 | 295,311 (0%) | 0% | 0 | Common Stock | ||
| Harvard Bioscience Inc | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 45,872 | 311,126 (0%) | 0% | 0 | Common Stock | |
| BuzzFeed Inc (Class A) | Matthew Omer | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 21 May 2024 | 45,499 | 99,100 | - | 0 | Class A Common Stock | |
| Carlyle Grp Inc | Harvey M. Schwartz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 44,052 | 7,042,876 (2%) | 0% | 0 | Common Stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 43,825 | 43,825 | - | - | Non-Qualified Stock Option (right to buy) | |
| Biodesix Inc | Lawrence T. Kennedy | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 43,478 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Honest Co Inc (The ) | Carla Vernon | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 21 May 2024 | 43,317 | 2,881,070 | - | 2.8 | 119,988 | Common Stock |
| Nextracker Inc (Class A) | Nicholas Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 41,956 | 110,235 | - | 0 | Common Stock | |
| Invivyd Inc | Sara Cotter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 41,369 | 41,369 | - | - | Stock Option (Right to Buy) | |
| BuzzFeed Inc (Class A) | David Arroyo | CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 21 May 2024 | 41,102 | 72,217 | - | 0 | Class A Common Stock | |
| Curis Inc | Jonathan B. Zung | CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 40,700 | 40,700 | - | - | Employee stock option (right to buy) | |
| Telos Corp | Bradley W. Jacobs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 40,323 | 146,095 | - | 0 | Common Stock | |
| Telos Corp | David Borland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 40,323 | 131,620 | - | 0 | Common Stock | |
| Telos Corp | Bonnie Carroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 40,323 | 131,848 | - | 0 | Common Stock | |
| Telos Corp | John W. Maluda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 40,323 | 175,784 | - | 0 | Common Stock | |
| Telos Corp | Derrick D. Dockery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 40,323 | 124,902 | - | 0 | Common Stock | |
| Passage Bio Inc | Dolan Sondhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 39,092 | 39,092 | - | - | Director Stock Option (right to buy) | |
| Curis Inc | Diantha Duvall | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 39,000 | 39,000 | - | - | Employee stock option (right to buy) | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | Jack W. Schuler | Director, Ten Percent Owner | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | ||
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | Charles Watts | Director | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | ||
| Biodesix Inc | Lawrence T. Kennedy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Integra Lifesciences Holdings Corp | Barbara B. Hill | Director | Purchase of securities on an exchange or from another person at price $ 27.40 per share. | 21 May 2024 | 36,350 | 36,350 (0%) | 0% | 27.4 | 995,816 | Common Stock |
| Tetra Technologies Inc | John Frederick Glick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,206 | 36,206 | - | - | Restricted Stock Units | |
| Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,111 | 95,451 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Allen R. Nissenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,111 | 92,597 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Mark H. Ravich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,111 | 108,831 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,111 | 93,525 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Andrea Heslin Smiley | Director | 21 May 2024 | 36,111 | 92,062 (0%) | 0% | 0 | Common Stock | ||
| Rockwell Medical Inc | Joan Lau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,111 | 63,111 (0%) | 0% | 0 | Common Stock | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 40.90 per share. | 21 May 2024 | 35,327 | 2,097,135 | - | 40.9 | 1,444,924 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 40.90 per share. | 21 May 2024 | 35,320 | 1,645,392 | - | 40.9 | 1,444,613 | Class A Common Stock |
| Falcon`s Beyond Global Inc (Class A) | Bruce A. Brown | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 35,000 | 50,000 | - | 0 | Class A Common Stock | |
| Booz Allen Hamilton Holding Corp (Class A) | Horacio D. Rozanski | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 154.15 per share. | 21 May 2024 | 34,571 | 579,025 (0%) | 0% | 154.2 | 5,329,120 | Class A Common Stock |
| Booz Allen Hamilton Holding Corp (Class A) | Horacio D. Rozanski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 154.15 per share. | 21 May 2024 | 34,571 | 579,025 (0%) | 0% | 154.2 | 5,329,120 | Class A Common Stock |
| NextNav Inc | Arun Raghupathy | Senior Vice President | 21 May 2024 | 34,453 | 1,096,085 | - | 7.8 | 267,355 | Common Stock | |
| Treace Medical Concepts Inc | John K. Bakewell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 33,260 | 33,260 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Lawrence W. Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 33,260 | 33,260 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Richard W. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 33,260 | 33,260 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Jane E. Kiernan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 33,260 | 33,260 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Lance A. Berry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 33,260 | 33,260 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Deepti Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 33,260 | 33,260 | - | - | Stock Option (Right to Buy) | |
| Treace Medical Concepts Inc | Elizabeth S. Hanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 33,260 | 33,260 | - | - | Stock Option (Right to Buy) | |
| Snowflake Inc (Class A) | Sridhar Ramaswamy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 32,188 | 287,911 | - | 0 | Class A Common Stock | |
| The Baldwin Insurance Grp Inc (Class A) | Lowry Baldwin | Director, Ten Percent Owner, See Remarks | Sale of securities on an exchange or to another person at price $ 33.68 per share. | 21 May 2024 | 32,110 | 92,890 (0%) | 0% | 33.7 | 1,081,465 | Class A Common Stock |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 31,960 | 2,026,142 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 31,960 | 194,600 | - | - | Restricted Stock Unit Award | |
| Nextracker Inc (Class A) | Nicholas Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 31,881 | 31,881 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | Michael G. Raab | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 21 May 2024 | 31,484 | 1,277,773 (1%) | 0% | 7.8 | 245,922 | Common Stock |
| International Bancshares Corp | Antonio R. Sanchez | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 59.75 per share. | 21 May 2024 | 30,112 | 1,282,133 (1%) | 0% | 59.8 | 1,799,192 | Common Stock |
| FTI Consulting Inc | Steven H. Gunby | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 21 May 2024 | 30,000 | 257,184 (0%) | 0% | 0 | Common Stock | |
| Walmart | Timothy Patrick Flynn | Director | Sale of securities on an exchange or to another person at price $ 64.82 per share. | 21 May 2024 | 30,000 | 0 (0%) | 0% | 64.8 | 1,944,609 | Common |
| McKesson | Brian S. Tyler | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 552.39 per share. | 21 May 2024 | 29,135 | 86,336 (0%) | 0% | 552.4 | 16,093,883 | Common Stock |
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 35.44 per share. | 21 May 2024 | 28,417 | 639,565 (0%) | 0% | 35.4 | 1,007,127 | Class A Common Stock |
| Synovus Fin Corp | Andrew J. Gregory | EVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 40.02 per share. | 21 May 2024 | 28,000 | 49,256 (0%) | 0% | 40.0 | 1,120,700 | Common Stock |
| Shimmick Corp | J. Brendan Herron | Director | 21 May 2024 | 28,000 | 28,000 | - | 1.6 | 45,360 | Common Stock | |
| Nextracker Inc (Class A) | Leah Schlesinger | GC, Ch Eth & Compl Offr & Sec | 21 May 2024 | 27,970 | 87,517 | - | 0 | Common Stock | ||
| Exelixis Inc | Julie Anne Smith | Director | Sale of securities on an exchange or to another person at price $ 21.12 per share. | 21 May 2024 | 27,280 | 5,445 (0%) | 0% | 21.1 | 576,154 | Common Stock |
| American Superconductor Corp | John W. Kosiba | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 14.78 per share. | 21 May 2024 | 26,830 | 350,306 (1%) | 0% | 14.8 | 396,614 | Common Stock |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 26,791 | 26,791 | - | - | Stock Option (Right To Buy) | |
| Tetra Technologies Inc | Mark E. Baldwin | Director | 21 May 2024 | 26,551 | 26,551 | - | - | Restricted Stock Units | ||
| Tetra Technologies Inc | Thomas R. Bates | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 26,551 | 26,551 | - | - | Restricted Stock Units | |
| Tetra Technologies Inc | Christian A. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 26,551 | 26,551 | - | - | Restricted Stock Units | |
| Tetra Technologies Inc | Shawn D. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 26,551 | 26,551 | - | - | Restricted Stock Units | |
| Tetra Technologies Inc | Sharon Booth McGee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 26,551 | 26,551 | - | - | Restricted Stock Units | |
| Tetra Technologies Inc | Angela D. John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 26,551 | 26,551 | - | - | Restricted Stock Units | |
| Nextracker Inc (Class A) | Nicholas Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 26,429 | 47,546 | - | - | Performance Stock Units | |
| SoFi Tech Inc | Harvey M. Schwartz | Director | 21 May 2024 | 26,249 | 0 | - | - | Restricted Stock Unit | ||
| SoFi Tech Inc | Harvey M. Schwartz | Director | 21 May 2024 | 26,249 | 361,289 | - | - | Common Stock | ||
| SoFi Tech Inc | Ahmed Ali Al-Hammadi | Director | 21 May 2024 | 26,249 | 0 | - | - | Restricted Stock Unit | ||
| SoFi Tech Inc | Ahmed Ali Al-Hammadi | Director | 21 May 2024 | 26,249 | 87,937 | - | - | Common Stock | ||
| SoFi Tech Inc | Clara Liang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 26,249 | 62,223 | - | - | Common Stock | |
| SoFi Tech Inc | Clara Liang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 26,249 | 0 | - | - | Restricted Stock Unit | |
| SoFi Tech Inc | Bashir Ruzwana | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 26,249 | 0 | - | - | Restricted Stock Unit | |
| SoFi Tech Inc | Bashir Ruzwana | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 26,249 | 77,937 | - | - | Common Stock | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.74 per share. | 21 May 2024 | 25,849 | 5,056,989 | - | 36.7 | 949,796 | Common Stock |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 32.70 per share. | 21 May 2024 | 25,000 | 4,619,432 | - | 32.7 | 817,500 | Ordinary Shares |
| Fathom Holdings Inc | Scott N. Flanders | Director | Purchase of securities on an exchange or from another person at price $ 1.65 per share. | 21 May 2024 | 25,000 | 596,335 | - | 1.7 | 41,250 | Common Stock |
| TMC the metals Co Inc | Anthony O’Sullivan | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.48 per share. | 21 May 2024 | 25,000 | 846,829 | - | 1.5 | 37,000 | Common Shares |
| TMC the metals Co Inc | Anthony O’Sullivan | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.40 per share. | 21 May 2024 | 25,000 | 871,829 | - | 1.4 | 35,110 | Common Shares |
| Great Elm Grp Inc | Matthew A. Drapkin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 21 May 2024 | 24,984 | 1,938,674 (7%) | 0% | 1.8 | 44,264 | Common Stock |
| Great Elm Grp Inc | Jason W. Reese | Director, See remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 21 May 2024 | 24,984 | 6,354,630 (24%) | 0% | 1.8 | 44,222 | Common stock, par value $0.01 per share ("Common Stock") |
| Acco Brands Corp | Edward Mark Rajkowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 24,951 | 191,975 | - | - | Restricted Stock Units | |
| Acco Brands Corp | Kathleen S. Dvorak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 24,951 | 208,468 | - | - | Restricted Stock Units | |
| Acco Brands Corp | Robert J. Keller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 24,951 | 161,963 | - | - | Restricted Stock Units | |
| Acco Brands Corp | Pradeep Jotwani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 24,951 | 183,857 | - | - | Restricted Stock Units | |
| Acco Brands Corp | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 24,951 | 134,951 (0%) | 0% | 0 | Common Stock | |
| Acco Brands Corp | Joseph B. Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 24,951 | 65,230 | - | - | Restricted Stock Units | |
| Acco Brands Corp | Graciela I. Monteagudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 24,951 | 144,112 | - | - | Restricted Stock Units | |
| Acco Brands Corp | Elizabeth A. Simermeyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 24,951 | 35,910 | - | - | Restricted Stock Units | |
| CuriosityStream Inc - Ordinary Shares- Class A | Peter M. Westley | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.06 per share. | 21 May 2024 | 24,922 | 139,295 | - | 1.1 | 26,293 | Common Stock |
| Dyadic Intl Inc, DE | Michael P. Tarnok | Director | 21 May 2024 | 24,431 | 221,672 (0%) | 0% | 1.7 | 40,800 | Common Stock | |
| Immuneering Corp (Class A) | Mallory Morales | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 23,850 | 23,850 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Mallory Morales | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 23,850 | 0 | - | - | Stock Option | |
| Synovus Fin Corp | Andrew J. Gregory | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.02 per share. | 21 May 2024 | 23,539 | 21,256 (0%) | 0% | 40.0 | 942,101 | Common Stock |
| Carpenter Tech Corp | James D. Dee | SVP Gen Counsel & Sec | Sale of securities on an exchange or to another person at price $ 111.26 per share. | 21 May 2024 | 23,518 | 84,798 (0%) | 0% | 111.3 | 2,616,660 | Common Stock |
| Nextracker Inc (Class A) | David Bennett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 23,214 | 41,762 | - | - | Performance Stock Units | |
| Nextracker Inc (Class A) | Leah Schlesinger | GC, Ch Eth & Compl Offr & Sec | 21 May 2024 | 23,214 | 41,762 | - | - | Performance Stock Units | ||
| QuantumScape Corp (Class A) | Michael O. McCarthy | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.72 per share. | 21 May 2024 | 22,554 | 1,207,500 | - | 5.7 | 128,937 | Class A Common Stock |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| 4D Molecular Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| 4D Molecular Therapeutics Inc | Nancy Miller-Rich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| 4D Molecular Therapeutics Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| Aflac Inc | Charles Ditmars Lake | Chairman & Rep. Director, ALIJ | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 22,378 | 0 | - | - | Employee Stock Option (right to buy) | |
| Aflac Inc | Charles Ditmars Lake | Chairman & Rep. Director, ALIJ | Sale of securities on an exchange or to another person at price $ 87.47 per share. | 21 May 2024 | 22,378 | 61,522 (0%) | 0% | 87.5 | 1,957,426 | Common Stock |
| Aflac Inc | Charles Ditmars Lake | Chairman & Rep. Director, ALIJ | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.72 per share. | 21 May 2024 | 22,378 | 83,900 (0%) | 0% | 30.7 | 687,564 | Common Stock |
| Murphy USA Inc | R. Andrew Clyde | Director, President & CEO | 21 May 2024 | 22,300 | 221,863 (0%) | 0% | 0 | Common Stock | ||
| Murphy USA Inc | R. Andrew Clyde | Director, President & CEO | 21 May 2024 | 22,300 | 22,300 | - | - | Stock Option | ||
| AlTi Global Inc (Class A) | Michael Tiedemann | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.39 per share. | 21 May 2024 | 22,296 | 431,441 | - | 4.4 | 97,879 | Class A Common Stock |
| Roblox Corp (Class A) | Michael Guthrie | Chief Financial Officer | 21 May 2024 | 22,076 | 374,633 | - | 32.6 | 718,772 | Class A Common Stock | |
| Nextracker Inc (Class A) | Leah Schlesinger | GC, Ch Eth & Compl Offr & Sec | 21 May 2024 | 21,254 | 21,254 | - | - | Stock Option (Right to Buy) | ||
| AlTi Global Inc (Class A) | Michael Tiedemann | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.41 per share. | 21 May 2024 | 21,072 | 452,513 | - | 4.4 | 92,928 | Class A Common Stock |
| NBT Bancorp. Inc | John H. Watt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 20,678 | 163,101 (0%) | 0% | 0 | NBT Bancorp Inc. Common Stock | |
| McKesson | Britt J. Vitalone | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 20,580 | 34,608 (0%) | 0% | 0 | Common Stock | |
| Great Elm Grp Inc | Matthew A. Drapkin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 21 May 2024 | 20,001 | 1,958,675 (7%) | 0% | 1.8 | 35,268 | Common Stock |
| Great Elm Grp Inc | Jason W. Reese | Director, See remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 21 May 2024 | 20,001 | 6,374,631 (25%) | 0% | 1.8 | 35,202 | Common Stock |
| iPower Inc | Chenlong Tan | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 21 May 2024 | 20,000 | 8,063,334 | - | 1.5 | 30,900 | Common Stock |
| Pioneer Bancorp Inc | Kelli Arnold | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Pioneer Bancorp Inc | Thomas Signor | EVP and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| AlTi Global Inc (Class A) | Michael Tiedemann | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.52 per share. | 21 May 2024 | 20,000 | 472,513 | - | 4.5 | 90,400 | Class A Common Stock |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 20,000 | 1,160,000 | - | - | Restricted Stock Unit Award | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 20,000 | 2,046,142 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Amprius Tech Inc | Kang Sun | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 21 May 2024 | 19,973 | 1,399,697 | - | 1.3 | 26,516 | Common stock |
| Arvinas Inc | Randy Teel | Int. Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 19,675 | 19,675 | - | - | Stock Option (right to buy) | |
| RingCentral Inc (Class A) | John Marlow | SVP, CAO & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 35.92 per share. | 21 May 2024 | 19,397 | 425,368 (0%) | 0% | 35.9 | 696,682 | Class A Common Stock |
| Redwood Trust Inc | Debora D. Horvath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 19,201 | 19,201 | - | - | Deferred Stock Units | |
| Redwood Trust Inc | Douglas B. Hansen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 19,201 | 19,201 | - | - | Deferred Stock Units | |
| Redwood Trust Inc | Greg H. Kubicek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 19,201 | 19,201 | - | - | Deferred Stock Units | |
| Redwood Trust Inc | Georganne C. Proctor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 19,201 | 19,201 | - | - | Deferred Stock Units | |
| Redwood Trust Inc | Faith A. Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 19,201 | 19,201 | - | - | Deferred Stock Units | |
| Redwood Trust Inc | Armando Falcon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 19,201 | 19,201 | - | - | Deferred Stock Units | |
| Redwood Trust Inc | Doneene K. Damon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 19,201 | 19,201 | - | - | Deferred Stock Units | |
| American Superconductor Corp | Daniel P. McGahn | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 14.78 per share. | 21 May 2024 | 18,939 | 1,058,741 (4%) | 0% | 14.8 | 279,947 | Common Stock |
| Coursera Inc | Andrew Y. Ng | Director | Sale of securities on an exchange or to another person at price $ 8.10 per share. | 21 May 2024 | 18,870 | 7,032,873 | - | 8.1 | 152,907 | Common Stock |
| Coursera Inc | Andrew Y. Ng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 18,669 | 7,051,743 | - | 0 | Common Stock | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 181.33 per share. | 21 May 2024 | 18,177 | 2,027,965 (0%) | 0% | 181.3 | 3,296,126 | Common Stock, par value $.01 per share |
| Roblox Corp (Class A) | Arvind Chakravarthy | Chief People & Systems Officer | Sale of securities on an exchange or to another person at price $ 32.56 per share. | 21 May 2024 | 18,165 | 322,966 | - | 32.6 | 591,434 | Class A Common Stock |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 18,037 | 32,326 (0%) | 0% | 75.6 | 1,363,606 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 18,037 | 0 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 18,037 | 50,363 (0%) | 0% | 24.5 | 442,808 | Common Stock | |
| Valley National Bancorp | Marc J. Lenner | Director | 21 May 2024 | 17,787 | 0 (0%) | 0% | 0 | Common Stock | ||
| Liberty Global PLC (Class A) | J. David Wargo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,661 | 17,661 | - | - | Share Option C (right to buy) | |
| Liberty Global PLC (Class A) | J. David Wargo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,661 | 17,661 | - | - | Share Option A (right to buy) | |
| Liberty Global PLC (Class A) | Larry E. Romrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,661 | 17,661 | - | - | Share Option A (right to buy) | |
| Liberty Global PLC (Class A) | Larry E. Romrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,661 | 17,661 | - | - | Share Option C (right to buy) | |
| Liberty Global PLC (Class A) | Miranda Curtis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,661 | 17,661 | - | - | Share Option A (right to buy) | |
| Liberty Global PLC (Class A) | Miranda Curtis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,661 | 17,661 | - | - | Share Option C (right to buy) | |
| Liberty Global PLC (Class A) | Richard R. Green | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,661 | 17,661 | - | - | Share Option C (right to buy) | |
| Liberty Global PLC (Class A) | Richard R. Green | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,661 | 17,661 | - | - | Share Option A (right to buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,530 | 104,368 | - | 0 | Common Stock | |
| Inspirato Incorporated (Class A) | Robert Kaiden | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.02 per share. | 21 May 2024 | 17,283 | 108,749 | - | 4.0 | 69,564 | Class A Common Stock |
| Dyadic Intl Inc, DE | Michael P. Tarnok | Director | 21 May 2024 | 16,875 | 0 | - | - | Stock Option | ||
| Dyadic Intl Inc, DE | Michael P. Tarnok | Director | 21 May 2024 | 16,875 | 246,103 (0%) | 0% | 1.4 | 22,950 | Common Stock | |
| Roblox Corp (Class A) | Mark Reinstra | Gen. Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 32.56 per share. | 21 May 2024 | 16,797 | 342,656 | - | 32.6 | 546,894 | Class A Common Stock |
| Nextracker Inc (Class A) | David Bennett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,782 | 128,508 | - | 0 | Common Stock | |
| Macrogenics Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | William K. Heiden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Margaret A. Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Margaret A. Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Scott T. Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Karen Jean Ferrante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Jay Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Federica O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | Margaret A. Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Employee Stock Option (right to buy) | |
| Valley National Bancorp | Andrew B. Abramson | Director | 21 May 2024 | 16,451 | 224,679 (0%) | 0% | 7.7 | 127,002 | Common Stock | |
| SM Energy Co | Kenneth J. Knott | SVP - Bus Dev & Land | Sale of securities on an exchange or to another person at price $ 50.28 per share. | 21 May 2024 | 16,000 | 114,495 (0%) | 0% | 50.3 | 804,480 | Common Stock, $.01 Par Value |
| Amprius Tech Inc | Kang Sun | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 1.36 per share. | 21 May 2024 | 15,611 | 1,384,086 | - | 1.4 | 21,169 | Common stock |
| Walmart | Christopher Nicholas | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.18 per share. | 21 May 2024 | 15,431 | 351,448 (0%) | 0% | 64.2 | 990,366 | Common |
| Treace Medical Concepts Inc | John K. Bakewell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,091 | 150,139 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Lawrence W. Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,091 | 20,139 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Richard W. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,091 | 1,042,844 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Jane E. Kiernan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,091 | 40,032 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Lance A. Berry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,091 | 20,676 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Deepti Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,091 | 46,326 | - | 0 | Common Stock | |
| Treace Medical Concepts Inc | Elizabeth S. Hanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,091 | 21,326 | - | 0 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 15,006 | 0 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 15,006 | 32,326 (0%) | 0% | 76.0 | 1,140,633 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 15,006 | 47,332 (0%) | 0% | 27.1 | 406,513 | Common Stock | |
| CoreCivic Inc | Anthony L. Grande | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.51 per share. | 21 May 2024 | 15,000 | 168,380 (0%) | 0% | 15.5 | 232,650 | Common Stock |
| Immuneering Corp (Class A) | Mallory Morales | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,000 | 15,000 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Mallory Morales | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 15,000 | 0 | - | - | Stock Option | |
| Pioneer Bancorp Inc | Eileen C. Bagnoli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Pioneer Bancorp Inc | Madeline Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,000 | 24,100 (0%) | 0% | 0 | Common Stock | |
| Pioneer Bancorp Inc | Edward Reinfurt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 15,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | William F. Doyle | Director | 21 May 2024 | 15,000 | 76,330 (0%) | 0% | 17.0 | 254,700 | Common Stock | |
| BuzzFeed Inc (Class A) | Daniel Weinstein | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 14,999 | 30,001 | - | - | Restricted Stock Units | |
| BuzzFeed Inc (Class A) | Daniel Weinstein | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 14,999 | 14,999 | - | 0 | Class A Common Stock | |
| DXC Tech Co | Christopher A. Voci | SVP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 14,875 | 100,309 (0%) | 0% | 0 | Common Stock | |
| Healthcare Realty Trust Inc (Class A) | Nancy Howell Agee | Director | 21 May 2024 | 14,634 | 21,762 | - | - | Partnership Units | ||
| Amazon | Brian T. Olsavsky | Senior Vice President and CFO | Sale of securities on an exchange or to another person at price $ 182.11 per share. | 21 May 2024 | 14,600 | 49,000 (0%) | 0% | 182.1 | 2,658,806 | Common Stock, par value $.01 per share |
| Healthcare Realty Trust Inc (Class A) | Peter F. Lyle | Director | 21 May 2024 | 14,462 | 21,590 | - | - | Partnership Units | ||
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 14,170 | 55,150 (0%) | 0% | 0 | Common Stock | |
| Washington Federal Inc | Cathy E. Cooper | EVP & Chief Consumer Banker | Sale of securities on an exchange or to another person at price $ 28.52 per share. | 21 May 2024 | 14,000 | 88,691 (0%) | 0% | 28.5 | 399,273 | Common Stock |
| Ritchie Bros Auctioneers Inc | James J. Jeter | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.64 per share. | 21 May 2024 | 14,000 | 42,267 (0%) | 0% | 40.6 | 568,960 | Common Shares |
| Ritchie Bros Auctioneers Inc | James J. Jeter | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 14,000 | 3,072 | - | - | Employee Stock Option (Right to Buy) | |
| Ritchie Bros Auctioneers Inc | James J. Jeter | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 75.43 per share. | 21 May 2024 | 14,000 | 28,267 (0%) | 0% | 75.4 | 1,056,020 | Common Shares |
| biote Corp (Class A) | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 13,427 | 25,436 | - | - | Deferred Settlement RSU | |
| Arvinas Inc | Randy Teel | Int. Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 13,300 | 59,341 (0%) | 0% | 0 | Common Stock | |
| Ritchie Bros Auctioneers Inc | Baron Concors | Chief Product & Tech. Officer | Sale of securities on an exchange or to another person at price $ 75.05 per share. | 21 May 2024 | 13,230 | 15,487 (0%) | 0% | 75.1 | 992,912 | Common Shares |
| Biodesix Inc | Robin Harper Cowie | CFO, Secy & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 13,080 | 188,969 | - | - | Common Stock | |
| biote Corp (Class A) | Dana Jacoby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 12,994 | 12,994 | - | - | Deferred Settlement RSU | |
| Innovative Soln And Support Inc | Glen R. Bressner | Director | Purchase of securities on an exchange or from another person at price $ 5.55 per share. | 21 May 2024 | 12,891 | 116,092 (0%) | 0% | 5.5 | 71,542 | Common Stock |
| CuriosityStream Inc - Ordinary Shares- Class A | Peter M. Westley | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.06 per share. | 21 May 2024 | 12,831 | 126,464 | - | 1.1 | 13,537 | Common Stock |
| RingCentral Inc (Class A) | John Marlow | SVP, CAO & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 35.44 per share. | 21 May 2024 | 12,728 | 412,540 (0%) | 0% | 35.4 | 451,119 | Class A Common Stock |
| EOG Resources | Ezra Y. Yacob | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 12,725 | 12,764 | - | - | Stock Appreciation Rights | |
| EOG Resources | Ezra Y. Yacob | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.81 per share. | 21 May 2024 | 12,725 | 163,199 (0%) | 0% | 81.8 | 1,041,032 | Common Stock |
| Amazon | Douglas J. Herrington | CEO Worldwide Amazon Stores | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 12,640 | 77,020 | - | - | Restricted Stock Unit Award | |
| Amazon | Douglas J. Herrington | CEO Worldwide Amazon Stores | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 12,640 | 530,249 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| First Solar | Caroline Stockdale | Chief People and Comm. Officer | Sale of securities on an exchange or to another person at price $ 205.00 per share. | 21 May 2024 | 12,406 | 22,025 (0%) | 0% | 205 | 2,543,230 | Common Stock |
| Acacia Research Corp | Gavin T. Molinelli | Director | Grant, award, or other acquisition of securities at price $ 5.68 per share. | 21 May 2024 | 12,104 | 57,498 (0%) | 0% | 5.7 | 68,751 | Common Stock, par value $0.001 |
| Intapp Inc | Thad Jampol | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 36.74 per share. | 21 May 2024 | 12,011 | 753,183 | - | 36.7 | 441,332 | Common Stock |
| Certara Inc | Cynthia Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Certara Inc | Matthew M. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Certara Inc | Eran Broshy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Certara Inc | James E. Cashman | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Certara Inc | Rosemary A. Crane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Certara Inc | Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Murphy USA Inc | R. Andrew Clyde | Director, President & CEO | 21 May 2024 | 11,908 | 209,955 (0%) | 0% | 443.9 | 5,286,438 | Common Stock | |
| Exelixis Inc | George H. Poste | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 11,686 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | George H. Poste | Director | Sale of securities on an exchange or to another person at price $ 20.96 per share. | 21 May 2024 | 11,686 | 213,907 (0%) | 0% | 21.0 | 244,939 | Common Stock |
| Exelixis Inc | George H. Poste | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.57 per share. | 21 May 2024 | 11,686 | 225,593 (0%) | 0% | 19.6 | 228,695 | Common Stock |
| biote Corp (Class A) | Dana Jacoby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 11,595 | 0 | - | - | Deferred Settlement RSU | |
| biote Corp (Class A) | Dana Jacoby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 11,595 | 50,970 | - | - | Class A Common Stock | |
| Amazon | David A. Zapolsky | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 11,360 | 69,160 | - | - | Restricted Stock Unit Award | |
| Amazon | David A. Zapolsky | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 11,360 | 70,460 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Amazon | Brian T. Olsavsky | Senior Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 11,360 | 60,360 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Amazon | Brian T. Olsavsky | Senior Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 11,360 | 69,160 | - | - | Restricted Stock Unit Award | |
| Oncology Institute Inc | Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.60 per share. | 21 May 2024 | 11,173 | 718,430 | - | 0.6 | 6,673 | Common Stock |
| Amprius Tech Inc | Jonathan Bornstein | President of Amprius Lab | 21 May 2024 | 11,171 | 1,555,626 | - | 1.3 | 14,831 | Common stock | |
| Joby Aviation Inc | Greg Bowles | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 11,156 | 64,350 | - | 0 | Common Stock | |
| Joby Aviation Inc | Greg Bowles | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 11,156 | 122,716 | - | - | Restricted Stock Units (RSUs) | |
| biote Corp (Class A) | Debra L. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,045 | 11,045 | - | - | Deferred Settlement RSU | |
| Valley National Bancorp | Eric P. Edelstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 10,982 | 131,691 (0%) | 0% | 0 | Common Stock | |
| Valley National Bancorp | Jeffrey S. Wilks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 10,982 | 91,643 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.